nodes	percent_of_prediction	percent_of_DWPC	metapath
Proflavine—F2—leg—multiple sclerosis	0.168	0.677	CbGeAlD
Proflavine—F2—Cell surface interactions at the vascular wall—SELPLG—multiple sclerosis	0.0301	0.0401	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—CD58—multiple sclerosis	0.0301	0.0401	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—MERTK—multiple sclerosis	0.0301	0.0401	CbGpPWpGaD
Proflavine—F2—spinal cord—multiple sclerosis	0.0243	0.0981	CbGeAlD
Proflavine—F2—nervous system—multiple sclerosis	0.0205	0.0827	CbGeAlD
Proflavine—F2—central nervous system—multiple sclerosis	0.0197	0.0796	CbGeAlD
Proflavine—F2—Syndecan-4-mediated signaling events—CCL5—multiple sclerosis	0.018	0.0239	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—ICAM1—multiple sclerosis	0.0174	0.0232	CbGpPWpGaD
Proflavine—F2—brain—multiple sclerosis	0.0157	0.0632	CbGeAlD
Proflavine—F2—IL1 and megakaryotyces in obesity—CCL2—multiple sclerosis	0.0156	0.0208	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—IFNG—multiple sclerosis	0.0133	0.0177	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—SELE—multiple sclerosis	0.0131	0.0174	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—CCL5—multiple sclerosis	0.0124	0.0165	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—IL1B—multiple sclerosis	0.0118	0.0157	CbGpPWpGaD
Proflavine—F2—IL1 and megakaryotyces in obesity—MMP9—multiple sclerosis	0.0112	0.0148	CbGpPWpGaD
Proflavine—F2—G alpha (q) signalling events—GPR65—multiple sclerosis	0.0104	0.0138	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—APOE—multiple sclerosis	0.0102	0.0135	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	0.00979	0.013	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL4—multiple sclerosis	0.00977	0.013	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	0.00954	0.0127	CbGpPWpGaD
Proflavine—F2—Cell surface interactions at the vascular wall—ITGA4—multiple sclerosis	0.00948	0.0126	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCL13—multiple sclerosis	0.00939	0.0125	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCR1—multiple sclerosis	0.00939	0.0125	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—multiple sclerosis	0.0093	0.0124	CbGpPWpGaD
Proflavine—F2—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	0.00895	0.0119	CbGpPWpGaD
Proflavine—F2—Syndecan-4-mediated signaling events—MMP9—multiple sclerosis	0.00887	0.0118	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.00854	0.0114	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—CCL2—multiple sclerosis	0.00854	0.0114	CbGpPWpGaD
Proflavine—F2—Hemostasis—MERTK—multiple sclerosis	0.00817	0.0109	CbGpPWpGaD
Proflavine—F2—Hemostasis—SELPLG—multiple sclerosis	0.00817	0.0109	CbGpPWpGaD
Proflavine—F2—Hemostasis—CD58—multiple sclerosis	0.00817	0.0109	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—ALB—multiple sclerosis	0.00796	0.0106	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—ICAM1—multiple sclerosis	0.00776	0.0103	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IFNG—multiple sclerosis	0.00726	0.00966	CbGpPWpGaD
Proflavine—F2—Thrombin signalling through proteinase activated receptors (PARs)—MAPK1—multiple sclerosis	0.00717	0.00953	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—CCL2—multiple sclerosis	0.00695	0.00924	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.00689	0.00916	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL3—multiple sclerosis	0.00669	0.0089	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—S1PR1—multiple sclerosis	0.00651	0.00865	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IL1B—multiple sclerosis	0.00648	0.00861	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—ALB—multiple sclerosis	0.00647	0.00861	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.0063	0.00838	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.0063	0.00838	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCR3—multiple sclerosis	0.00622	0.00827	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.00617	0.0082	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCR2—multiple sclerosis	0.00605	0.00805	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IFNG—multiple sclerosis	0.00591	0.00786	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.00552	0.00734	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL1B—multiple sclerosis	0.00527	0.00701	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL2—multiple sclerosis	0.00525	0.00698	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—GPR65—multiple sclerosis	0.00524	0.00698	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.00514	0.00684	CbGpPWpGaD
Proflavine—F2—Hemostasis—PLEK—multiple sclerosis	0.00504	0.00671	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CXCL10—multiple sclerosis	0.00503	0.00669	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—MAPK1—multiple sclerosis	0.00501	0.00667	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCL13—multiple sclerosis	0.0048	0.00638	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCR1—multiple sclerosis	0.0048	0.00638	CbGpPWpGaD
Proflavine—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—multiple sclerosis	0.00477	0.00635	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—TNF—multiple sclerosis	0.0047	0.00625	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.00469	0.00624	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	0.00449	0.00597	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL5—multiple sclerosis	0.00433	0.00576	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	0.00432	0.00575	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.00419	0.00557	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	0.00417	0.00555	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	0.00406	0.0054	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—SLC30A7—multiple sclerosis	0.00397	0.00528	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCR5—multiple sclerosis	0.0039	0.00519	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—TNF—multiple sclerosis	0.00382	0.00509	CbGpPWpGaD
Proflavine—F2—Vitamin B12 Metabolism—IL6—multiple sclerosis	0.00379	0.00504	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	0.00375	0.00498	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—S1PR1—multiple sclerosis	0.00368	0.00489	CbGpPWpGaD
Proflavine—F2—Hemostasis—SELE—multiple sclerosis	0.00355	0.00473	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL3—multiple sclerosis	0.00342	0.00455	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	0.00341	0.00453	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	0.00337	0.00449	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—S1PR1—multiple sclerosis	0.00334	0.00444	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—PTGER4—multiple sclerosis	0.00329	0.00438	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—PABPC1—multiple sclerosis	0.00321	0.00427	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCR3—multiple sclerosis	0.00318	0.00423	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—RGS1—multiple sclerosis	0.00313	0.00416	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCR2—multiple sclerosis	0.00309	0.00411	CbGpPWpGaD
Proflavine—F2—Folate Metabolism—IL6—multiple sclerosis	0.00309	0.0041	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—POMC—multiple sclerosis	0.00305	0.00405	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—TNF—multiple sclerosis	0.00304	0.00404	CbGpPWpGaD
Proflavine—F2—Peptide ligand-binding receptors—CCL2—multiple sclerosis	0.00298	0.00397	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—GPR65—multiple sclerosis	0.00296	0.00394	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.0029	0.00386	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—RPL5—multiple sclerosis	0.00289	0.00385	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CNR1—multiple sclerosis	0.00285	0.00379	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—RGS1—multiple sclerosis	0.00284	0.00378	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCR1—multiple sclerosis	0.00271	0.00361	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCL13—multiple sclerosis	0.00271	0.00361	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—GPR65—multiple sclerosis	0.00269	0.00358	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.00262	0.00348	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—LINGO1—multiple sclerosis	0.0026	0.00346	CbGpPWpGaD
Proflavine—F2—Hemostasis—ITGA4—multiple sclerosis	0.00257	0.00342	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CXCL10—multiple sclerosis	0.00257	0.00342	CbGpPWpGaD
Proflavine—F2—Hemostasis—IFNB1—multiple sclerosis	0.00255	0.00339	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—ALB—multiple sclerosis	0.00246	0.00327	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCL13—multiple sclerosis	0.00246	0.00327	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCR1—multiple sclerosis	0.00246	0.00327	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.00245	0.00326	CbGpPWpGaD
Proflavine—F2—Selenium Micronutrient Network—IL6—multiple sclerosis	0.00245	0.00326	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TAGAP—multiple sclerosis	0.00226	0.003	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL5—multiple sclerosis	0.00221	0.00294	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—BCHE—multiple sclerosis	0.00212	0.00282	CbGpPWpGaD
Proflavine—F2—Regulation of Actin Cytoskeleton—MAPK1—multiple sclerosis	0.00209	0.00278	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00204	0.00272	CbGpPWpGaD
Proflavine—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.002	0.00266	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	0.002	0.00266	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCR5—multiple sclerosis	0.00199	0.00265	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—S1PR1—multiple sclerosis	0.00197	0.00262	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—GPC5—multiple sclerosis	0.00192	0.00255	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—PTGER4—multiple sclerosis	0.00186	0.00247	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCR3—multiple sclerosis	0.0018	0.00239	CbGpPWpGaD
Proflavine—F2—Hemostasis—IL2RA—multiple sclerosis	0.00176	0.00233	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL3—multiple sclerosis	0.00175	0.00233	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCR2—multiple sclerosis	0.00175	0.00232	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—PTGER4—multiple sclerosis	0.00169	0.00225	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—RGS1—multiple sclerosis	0.00168	0.00223	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCR3—multiple sclerosis	0.00163	0.00217	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CNR1—multiple sclerosis	0.00161	0.00214	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—GPR65—multiple sclerosis	0.00159	0.00211	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCR2—multiple sclerosis	0.00159	0.00211	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.00156	0.00208	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	0.00156	0.00207	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—POMC—multiple sclerosis	0.00156	0.00207	CbGpPWpGaD
Proflavine—F2—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	0.00153	0.00203	CbGpPWpGaD
Proflavine—F2—GPCR ligand binding—CCL2—multiple sclerosis	0.00152	0.00203	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CNR1—multiple sclerosis	0.00146	0.00195	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCR1—multiple sclerosis	0.00145	0.00193	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCL13—multiple sclerosis	0.00145	0.00193	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CXCL10—multiple sclerosis	0.00145	0.00193	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CXCL10—multiple sclerosis	0.00132	0.00175	CbGpPWpGaD
Proflavine—F2—Hemostasis—ALB—multiple sclerosis	0.00127	0.00169	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCL5—multiple sclerosis	0.00125	0.00166	CbGpPWpGaD
Proflavine—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	0.0012	0.0016	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL5—multiple sclerosis	0.00113	0.00151	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—CCR5—multiple sclerosis	0.00113	0.0015	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—IL2RA—multiple sclerosis	0.00111	0.00148	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—POMC—multiple sclerosis	0.0011	0.00146	CbGpPWpGaD
Proflavine—F2—Metabolism of proteins—CCL2—multiple sclerosis	0.00107	0.00143	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL3—multiple sclerosis	0.00104	0.00138	CbGpPWpGaD
Proflavine—F2—Hemostasis—IL2—multiple sclerosis	0.00103	0.00137	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCR5—multiple sclerosis	0.00102	0.00136	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL2RA—multiple sclerosis	0.00101	0.00134	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PTGER4—multiple sclerosis	0.000997	0.00133	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—PGR—multiple sclerosis	0.000982	0.00131	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCR3—multiple sclerosis	0.000963	0.00128	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CD28—multiple sclerosis	0.000954	0.00127	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCR2—multiple sclerosis	0.000937	0.00125	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—POMC—multiple sclerosis	0.00088	0.00117	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CNR1—multiple sclerosis	0.000865	0.00115	CbGpPWpGaD
Proflavine—F2—Hemostasis—TGFB1—multiple sclerosis	0.000803	0.00107	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—POMC—multiple sclerosis	0.000799	0.00106	CbGpPWpGaD
Proflavine—F2—Hemostasis—MAPK1—multiple sclerosis	0.000787	0.00105	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—CCL2—multiple sclerosis	0.000782	0.00104	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CXCL10—multiple sclerosis	0.000779	0.00104	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—TYK2—multiple sclerosis	0.00071	0.000944	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CD86—multiple sclerosis	0.000681	0.000906	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL5—multiple sclerosis	0.00067	0.000891	CbGpPWpGaD
Proflavine—F2—GPCR downstream signaling—IL2—multiple sclerosis	0.00065	0.000865	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—SPP1—multiple sclerosis	0.000621	0.000826	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCR5—multiple sclerosis	0.000604	0.000803	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL2RA—multiple sclerosis	0.000595	0.000792	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL2—multiple sclerosis	0.000591	0.000786	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—APOE—multiple sclerosis	0.000549	0.000731	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CD80—multiple sclerosis	0.000497	0.000661	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—POMC—multiple sclerosis	0.000472	0.000628	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—CCL2—multiple sclerosis	0.000462	0.000614	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—MAPK1—multiple sclerosis	0.000452	0.000601	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TYK2—multiple sclerosis	0.000419	0.000558	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL2—multiple sclerosis	0.000349	0.000464	CbGpPWpGaD
Proflavine—F2—Signaling by GPCR—IL6—multiple sclerosis	0.000347	0.000462	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MMP9—multiple sclerosis	0.00033	0.000439	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—STAT3—multiple sclerosis	0.000294	0.00039	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MYC—multiple sclerosis	0.000273	0.000363	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—TGFB1—multiple sclerosis	0.000272	0.000362	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—MAPK1—multiple sclerosis	0.000267	0.000355	CbGpPWpGaD
Proflavine—F2—Signaling Pathways—IL6—multiple sclerosis	0.000205	0.000273	CbGpPWpGaD
